Conference Reports

Ticagrelor Plus Aspirin Reduces Risk of Stroke, Death in Patients With Atherosclerotic Stenosis
By Walter Alexander NEW YORK -- November 19, 2020 -- Treatment with ticagrelor plus aspirin in patients with atherosclerotic stenosis results in clinically meaningful reductions in risk of stroke and death versus treatment with aspirin alone, according to a study presented at the Virtual 2020...
Polypill Plus Aspirin Reduces Cardiovascular Disease by Almost 40% in Intermediate-Risk Individuals
By Walter Alexander NEW YORK -- November 17, 2020 -- Cardiovascular disease is reduced by as much as 40% in an intermediate-risk population without cardiovascular disease taking a polypill and aspirin, according to a study presented at the Virtual 2020 American Heart Association (AHA) Scientific...
Adding Dantrolene Sodium Suspension to Body Cooling Improves Outcomes in Patients With Exertional Heat Stroke
By Louise Gagnon OTTAWA, Ontario -- November 3, 2020 -- The adjunctive use of dantrolene sodium suspension to treat exertional heat stroke, in addition to body cooling, improved recovery of loss of consciousness, according to research presented at the 2020 Virtual Meeting of the American College...
SSRIs Reduce Depression, Improve Language Recovery After Stroke
By Louise Gagnon OTTAWA, Ontario -- October 14, 2020 -- Use of selective serotonin reuptake inhibitors (SSRIs) can lessen the impact of depression severity and enhance narrative speech content in patients who have experienced a stroke, according to a study presented at the 2020 Virtual Meeting of...
Patients With Diabetes Have Worse Outcomes After Mechanical Thrombectomy Than Non-Diabetic Patients
By Louise Gagnon OTTAWA, Ontario -- October 13, 2020 -- Patients with diabetes fare worse than non-diabetic patients after undergoing mechanical thrombectomy to treat large vessel occlusion, according to a study presented at the 2020 Virtual Meeting of the American Neurological Association (ANA...
Colchicine Reduces Risk of Major Cardiovascular Events in Patients With Coronary Artery Disease
By Eric Ramos CHICAGO -- September 7, 2020 -- Colchicine reduced the risk of major cardiovascular events in patients with chronic coronary artery disease, according to a study presented at the Virtual 2020 European Society of Cardiology (ESC) Congress. “The trial confirmed that low-dose...
Apabetalone Reduces Risk of Major Cardiovascular Events After Recent ACS in Patients With Diabetes, Kidney Disease
By Chris Berrie CEPAGATTI, Italy -- June 16, 2020 -- Apabetalone reduces the risk of major adverse cardiovascular events (MACE) by 50% versus placebo in patients with type 2 diabetes, recent acute coronary syndrome (ACS), and chronic kidney disease (CKD), according to a study presented at the 2020...
Portable MRI Scanners Can Be Used at Bedside to Evaluate Stroke
By Alex Morrisson WEST PALM BEACH, Fla -- May 4, 2020 -- A low-field MRI scanner is feasible for use at the bedside of patients exhibiting symptoms of stroke, according to a study presented at the 2020 Virtual Meeting of the American Academy of Neurology (AAN). Kevin Sheth, MD, Yale School of...
Cilostazol Helps Prevent Carotid In-Stent Restenosis
By Alex Morrisson LOS ANGELES -- February 25, 2020 -- Patients undergoing carotid artery stenting to prevent recurrence of stroke who receive cilostazol tend to have a lower incidence of in-stent restenosis after 2 years, according to a study presented here at the 2020 International Stroke...
Lowering Bad Cholesterol to 70 mg/dL Reduces Risk of Ischaemic Stroke
By Alex Morrisson LOS ANGELES -- February 24, 2020 -- In patients with a history of stroke or transient ischaemic attacks, reducing low density lipoprotein (LDL) cholesterol to a goal of 70 mg/dL significantly reduces the risk of subsequent cardiovascular events, according to a study presented...

Pages